Aarti Pharmalabs Limited has informed the Exchange regarding Grant of 57600 Options.
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aarti Pharmalabs Limited's Nomination and Remuneration Committee has approved the grant of 57,600 stock options to eligible employees of the company and its subsidiary. The options are granted under the APL Performance Stock Option Plan 2023 (PSOP 2023) at an exercise price of Rs. 5 per option. The grant is subject to SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. This is a routine employee compensation mechanism commonly used to align employee interests with shareholders.
The stock option grant is an internal employee incentive and has no direct impact on company financials or shareholder value in the near term. It may dilute EPS marginally upon exercise but is a standard practice for talent retention.